The aim of this review is to summarize current and emerging knowledge on the roles of PRMT1 and PRMT5 in BC and how targeting their methyltransferase activities specifically in BC subtypes could provide new therapeutic tools. This evidence concerns the gene PRMT1 and breast cancer.